BioGeometry Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $14.9M

  • Investors
  • 12

BioGeometry General Information

Description

Developer of a biologics design platform designed for protein design and optimization. The company's technology utilizes geometric deep learning and flow matching to enable epitope-specific antibody generation, de novo design, humanization, affinity analysis, and druglikeness analysis, providing pharmaceutical companies with a closed-loop system to accelerate large-molecule drug discovery and reduce research costs.

Contact Information

Website
www.biogeom.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 604, Building A, Rongke Information Center
  • Number. 2 South Road of the Chinese Academy of Sciences, Haidian District
  • Beijing, 100190
  • China
+86 157
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • Room 604, Building A, Rongke Information Center
  • Number. 2 South Road of the Chinese Academy of Sciences, Haidian District
  • Beijing, 100190
  • China
+86 157

BioGeometry Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioGeometry Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC (Series A1) 28-Oct-2026 $14.9M Completed Generating Revenue
4. Early Stage VC (Series A) 09-Jun-2026 Completed Generating Revenue
3. Early Stage VC Cancelled Generating Revenue
2. Early Stage VC 19-Jun-2024 $10M Completed Generating Revenue
1. Seed Round 21-Sep-2022 $10M $10M Completed Startup
To view BioGeometry’s complete valuation and funding history, request access »

BioGeometry Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioGeometry Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
CDB Venture Venture Capital Minority
China Life Investment Management Company Asset Manager Minority
Shanghai Healthcare Capital PE/Buyout Minority
Shanghai Rui Investment Fund Management Asset Manager Minority
Beijing Xinglian Zhaoji Private Equity Fund Management Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

BioGeometry FAQs

  • When was BioGeometry founded?

    BioGeometry was founded in 2021.

  • Where is BioGeometry headquartered?

    BioGeometry is headquartered in Beijing, China.

  • What is the size of BioGeometry?

    BioGeometry has 30 total employees.

  • What industry is BioGeometry in?

    BioGeometry’s primary industry is Discovery Tools (Healthcare).

  • Is BioGeometry a private or public company?

    BioGeometry is a Private company.

  • What is BioGeometry’s current revenue?

    The current revenue for BioGeometry is .

  • How much funding has BioGeometry raised over time?

    BioGeometry has raised $24.9M.

  • Who are BioGeometry’s investors?

    CDB Venture, China Life Investment Management Company, Shanghai Healthcare Capital, Shanghai Rui Investment Fund Management, and Beijing Xinglian Zhaoji Private Equity Fund Management are 5 of 12 investors who have invested in BioGeometry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process